At least nine drugmakers have modified their contract pharmacy restrictions in Arkansas after the state said it planned to enforce its 340B law following an appeals court decision. An additional nine manufacturers loosened restrictions prior to the court decision.
Four More Drugmakers to End 340B Contract Pharmacy Restrictions in Arkansas Following Appeals Court Decision
Bristol Myers Squibb (BMS), Amgen, and Bayer became the latest drugmakers to formally exempt Arkansas providers from their 340B contract [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
